Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Cord blood 25(OH)D and VA were significantly decreased, while PCT was elevated in BPD infants (all P < 0.05).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This prospective cohort study enrolled 144 preterm infants with gestational age ≤32 weeks admitted to the neonatal intensive care unit from March 2021 to December 2024.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants

Cohort study · Frontiers in Pediatrics · 2026

Original publication title

The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants

Xiaoxia Zhang; Chunmei Wan; Xiaomei Wang; Lan Jin; Shanshan Zhao; Xi Wang; Wenbin Dong

© 2026 Zhang, Wan, Wang, Jin, Zhao, Wang and Dong.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Umbilical arterial 25(OH)D is a stable independent predictive biomarker for BPD and provides valuable incremental predictive value beyond conventional clinical parameters, supporting early risk stratification in preterm infants, whereas VA exhibits limited predictive utility.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Despite substantial progress in the treatment of bronchopulmonary dysplasia (BPD), its overall incidence remains high, with increasing rates of moderate-to-severe cases. Reliable early biomarkers are urgently needed to facilitate timely intervention and optimize long-term prognosis.

Source: Background

Abstract: What methods does the paper describe?

This prospective cohort study enrolled 144 preterm infants with gestational age ≤32 weeks admitted to the neonatal intensive care unit from March 2021 to December 2024. Umbilical arterial blood was collected to detect 25(OH)D, vitamin A (VA), IL-6, PCT, and CRP levels. Infants were classified into BPD (n = 63) and non-BPD (n = 81) groups, and the BPD group was further stratified into Grade I, II, and III subgroups according to oxygen requirement and respiratory support. Group differences in biomarker levels and clinical variables were analyzed.

Univariate and multivariate logistic regression models were constructed to identify independent BPD predictors. ROC curves, DeLong test, NRI, and IDI were applied to evaluate incremental predictive performance.

Source: Methods

Abstract: Results

Cord blood 25(OH)D and VA were significantly decreased, while PCT was elevated in BPD infants (all P < 0.05). Within BPD subgroups, 25(OH)D gradually decreased and IL-6 increased with disease severity. Multivariate regression confirmed that cord blood 25(OH)D remained an independent protective factor for BPD after adjustment for gestational age, birth weight, and caffeine exposure (OR = 0.854, P < 0.001), whereas VA showed no independent predictive significance. The baseline clinical model yielded an AUC of 0.784. The addition of 25(OH)D significantly improved predictive efficacy to AUC = 0.857 (ΔAUC = 0.071, P = 0.001), with robust NRI and IDI improvements (both P < 0.001).

Further inclusion of VA produced no additional predictive benefit.

Source: Results

Abstract: Conclusion

Umbilical arterial 25(OH)D is a stable independent predictive biomarker for BPD and provides valuable incremental predictive value beyond conventional clinical parameters, supporting early risk stratification in preterm infants, whereas VA exhibits limited predictive utility.

Source: Conclusion
Authors’ abstract

Background

Despite substantial progress in the treatment of bronchopulmonary dysplasia (BPD), its overall incidence remains high, with increasing rates of moderate-to-severe cases. Reliable early biomarkers are urgently needed to facilitate timely intervention and optimize long-term prognosis.

Methods

This prospective cohort study enrolled 144 preterm infants with gestational age ≤32 weeks admitted to the neonatal intensive care unit from March 2021 to December 2024. Umbilical arterial blood was collected to detect 25(OH)D, vitamin A (VA), IL-6, PCT, and CRP levels. Infants were classified into BPD (n = 63) and non-BPD (n = 81) groups, and the BPD group was further stratified into Grade I, II, and III subgroups according to oxygen requirement and respiratory support. Group differences in biomarker levels and clinical variables were analyzed.

Univariate and multivariate logistic regression models were constructed to identify independent BPD predictors. ROC curves, DeLong test, NRI, and IDI were applied to evaluate incremental predictive performance.

Results

Cord blood 25(OH)D and VA were significantly decreased, while PCT was elevated in BPD infants (all P < 0.05). Within BPD subgroups, 25(OH)D gradually decreased and IL-6 increased with disease severity. Multivariate regression confirmed that cord blood 25(OH)D remained an independent protective factor for BPD after adjustment for gestational age, birth weight, and caffeine exposure (OR = 0.854, P < 0.001), whereas VA showed no independent predictive significance. The baseline clinical model yielded an AUC of 0.784. The addition of 25(OH)D significantly improved predictive efficacy to AUC = 0.857 (ΔAUC = 0.071, P = 0.001), with robust NRI and IDI improvements (both P < 0.001).

Further inclusion of VA produced no additional predictive benefit.

Conclusion

Umbilical arterial 25(OH)D is a stable independent predictive biomarker for BPD and provides valuable incremental predictive value beyond conventional clinical parameters, supporting early risk stratification in preterm infants, whereas VA exhibits limited predictive utility.

Publication and source details

Original title: The predictive value of cord blood 25-hydroxyvitamin D and vitamin A levels for bronchopulmonary dysplasia in preterm infants

Xiaoxia Zhang; Chunmei Wan; Xiaomei Wang; Lan Jin; Shanshan Zhao; Xi Wang; Wenbin Dong

Frontiers in Pediatrics · 2026

* Correspondence: Wenbin Dong dongwenbin2000@163.com
†

Present address: Xiaoxia Zhang, Department of Neonatology, Southern Central Hospital of Yunnan Province, The First People's Hospital of Honghe State, Yunnan Province, China

‡

These authors have contributed equally to this work

© 2026 Zhang, Wan, Wang, Jin, Zhao, Wang and Dong.2026Zhang, Wan, Wang, Jin, Zhao, Wang and Donghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.This study was supported by the National Natural Science Foundation of China (82371710).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T22:24:46.482616+00:00

DOI: 10.3389/fped.2026.1948901 · PMC13752065